GIST

• Comparative analysis of protein profiles of prognosis-associated proteins and KIT-related proteins in gastrointestinal stromal tumour
• Clinical profile of gastrointestinal stromal tumour in Yangon General Hospital
• Rare Cancers Europe
• Pathologic diagnosis: Improving accuracy in Asia and Europe
• Proffered Paper - Sarcoma - Invited Discussant LBA87
• INVICTUS: A Phase 3, INterVentional, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ripretinib as _4th-Line Therapy In...
• Neo-adjuvant (NA) Imatinib for gastrointestinal stromal tumours (GISTs): What is the optimal length of treatment?
• Gastrointestinal Stromal Tumours (GIST) in adolescents and young adults (AYA)
• Efficacy and safety of apatinib for advanced gastrointestinal stromal tumors after failure of imatinib and sunitinib: An open-label, multicenter, s...
• Radiomics of gastrointestinal stromal tumors; risk classification based on computed tomography images – a pilot study
• Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As and BTN3A1 in patients with metastatic gastrointestinal stromal tumors (mGISTs)
• Imaging of gastrointestinal stromal tumours
• Case-based panel discussion
• Systemic treatment
• ESMO 2019 Congress
• Sarcoma and GIST
• GIST
• Clinical correlation between different C-kit exon mutations and clinical outcome Imatinib mesylate treatment in Gist patients
• GIST
• Gastroenteropancreatic neuroendocrine tumors
• Clinicopathological features of wild-type GISTs based on multiple-gene panel analysis
• Extra-Gastrointestinal stromal tumor and tumor lysis syndrome, A case-report
• Reduced and re-escalated dose of sunitinib was adequately effective against gastrointestinal stromal tumor of the small intestine: a case report
• Synchronous adenocarcinoma and gastrointestinal stromal tumors in the stomach
• Retrospective Analysis of Outcome in GIST patients on Imatinib in Sarawak General Hospital: A Single Institution Experience

• « Previous
• 1
• 2
• ...
• 6
• Next »